H Lundbeck A/S (HLUN-A) - Net Assets

Latest as of December 2025: Dkr24.90 Billion DKK ≈ $3.90 Billion USD

Based on the latest financial reports, H Lundbeck A/S (HLUN-A) has net assets worth Dkr24.90 Billion DKK (≈ $3.90 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Dkr54.01 Billion ≈ $8.45 Billion USD) and total liabilities (Dkr29.11 Billion ≈ $4.55 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check H Lundbeck A/S (HLUN-A) asset resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Dkr24.90 Billion
% of Total Assets	46.11%
Annual Growth Rate	5.66%
5-Year Change	36.24%
10-Year Change	156.89%
Growth Volatility	12.9

H Lundbeck A/S - Net Assets Trend (2004–2025)

This chart illustrates how H Lundbeck A/S's net assets have evolved over time, based on quarterly financial data. Also explore total assets of H Lundbeck A/S for the complete picture of this company's asset base.

Annual Net Assets for H Lundbeck A/S (2004–2025)

The table below shows the annual net assets of H Lundbeck A/S from 2004 to 2025. For live valuation and market cap data, see H Lundbeck A/S market cap and net worth.

Year	Net Assets	Change
2025-12-31	Dkr24.90 Billion ≈ $3.90 Billion	-0.43%
2024-12-31	Dkr25.01 Billion ≈ $3.91 Billion	+13.45%
2023-12-31	Dkr22.05 Billion ≈ $3.45 Billion	+6.09%
2022-12-31	Dkr20.78 Billion ≈ $3.25 Billion	+13.68%
2021-12-31	Dkr18.28 Billion ≈ $2.86 Billion	+7.69%
2020-12-31	Dkr16.97 Billion ≈ $2.66 Billion	+16.62%
2019-12-31	Dkr14.55 Billion ≈ $2.28 Billion	+2.13%
2018-12-31	Dkr14.25 Billion ≈ $2.23 Billion	+16.99%
2017-12-31	Dkr12.18 Billion ≈ $1.91 Billion	+25.66%
2016-12-31	Dkr9.69 Billion ≈ $1.52 Billion	+10.35%
2015-12-31	Dkr8.79 Billion ≈ $1.37 Billion	-35.05%
2014-12-31	Dkr13.53 Billion ≈ $2.12 Billion	+0.33%
2013-12-31	Dkr13.48 Billion ≈ $2.11 Billion	+2.14%
2012-12-31	Dkr13.20 Billion ≈ $2.06 Billion	+3.30%
2011-12-31	Dkr12.78 Billion ≈ $2.00 Billion	+14.87%
2010-12-31	Dkr11.12 Billion ≈ $1.74 Billion	+26.34%
2009-12-31	Dkr8.80 Billion ≈ $1.38 Billion	+15.95%
2008-12-31	Dkr7.59 Billion ≈ $1.19 Billion	+5.66%
2007-12-31	Dkr7.18 Billion ≈ $1.12 Billion	+6.21%
2006-12-31	Dkr6.76 Billion ≈ $1.06 Billion	-9.70%
2005-12-31	Dkr7.49 Billion ≈ $1.17 Billion	-4.43%
2004-12-31	Dkr7.84 Billion ≈ $1.23 Billion	--

Equity Component Analysis

This analysis shows how different components contribute to H Lundbeck A/S's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 268.9% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	Dkr24.61 Billion	98.84%
Common Stock	Dkr996.00 Million	4.00%
Other Comprehensive Income	Dkr-706.00 Million	-2.83%
Total Equity	Dkr24.90 Billion	100.00%

H Lundbeck A/S Competitors by Market Cap

The table below lists competitors of H Lundbeck A/S ranked by their market capitalization.

Company	Market Cap
Omai Gold Mines Corp V:OMG	$1.09 Billion
Dharma Satya Nusantara Ptdsn JK:DSNG	$1.09 Billion
Arendals Fossekompani ASA OL:AFK	$1.09 Billion
Oaktree Specialty Lending Corp NASDAQ:OCSL	$1.09 Billion
Elders Ltd AU:ELD	$1.09 Billion
Beijing Strong Biotechnologies Inc SHE:300406	$1.09 Billion
Tiangong International Company Limited F:34T1	$1.09 Billion
OceanFirst Financial Corp NASDAQ:OCFC	$1.09 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in H Lundbeck A/S's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 25,010,000,000 to 24,903,000,000, a change of -107,000,000 (-0.4%).
Net income of 3,192,000,000 contributed positively to equity growth.
Dividend payments of 943,000,000 reduced retained earnings.
Share repurchases of 20,000,000 reduced equity.
Other comprehensive income decreased equity by 2,386,000,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Dkr3.19 Billion	+12.82%
Dividends Paid	Dkr943.00 Million	-3.79%
Share Repurchases	Dkr20.00 Million	-0.08%
Other Comprehensive Income	Dkr-2.39 Billion	-9.58%
Other Changes	Dkr50.00 Million	+0.2%
Total Change	Dkr-	-0.43%

Book Value vs Market Value Analysis

This analysis compares H Lundbeck A/S's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.39x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 5.13x to 1.39x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2004-12-31	Dkr6.82	Dkr35.00	x
2005-12-31	Dkr6.66	Dkr35.00	x
2006-12-31	Dkr6.41	Dkr35.00	x
2007-12-31	Dkr7.01	Dkr35.00	x
2008-12-31	Dkr7.71	Dkr35.00	x
2009-12-31	Dkr8.98	Dkr35.00	x
2010-12-31	Dkr11.34	Dkr35.00	x
2011-12-31	Dkr13.03	Dkr35.00	x
2012-12-31	Dkr13.46	Dkr35.00	x
2013-12-31	Dkr13.74	Dkr35.00	x
2014-12-31	Dkr13.77	Dkr35.00	x
2015-12-31	Dkr8.93	Dkr35.00	x
2016-12-31	Dkr9.82	Dkr35.00	x
2017-12-31	Dkr12.32	Dkr35.00	x
2018-12-31	Dkr14.34	Dkr35.00	x
2019-12-31	Dkr14.65	Dkr35.00	x
2020-12-31	Dkr17.08	Dkr35.00	x
2021-12-31	Dkr18.40	Dkr35.00	x
2022-12-31	Dkr20.93	Dkr35.00	x
2023-12-31	Dkr22.22	Dkr35.00	x
2024-12-31	Dkr25.23	Dkr35.00	x
2025-12-31	Dkr25.10	Dkr35.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently H Lundbeck A/S utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 12.82%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 13.11%
• Asset Turnover: 0.45x
• Equity Multiplier: 2.17x
Recent ROE (12.82%) is below the historical average (14.93%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2004	21.79%	17.56%	0.85x	1.47x	Dkr924.66 Million
2005	39.02%	32.23%	0.78x	1.55x	Dkr2.17 Billion
2006	31.91%	23.41%	0.79x	1.72x	Dkr1.48 Billion
2007	46.67%	30.53%	0.89x	1.72x	Dkr2.64 Billion
2008	36.04%	24.25%	0.89x	1.66x	Dkr1.98 Billion
2009	22.80%	14.60%	0.80x	1.95x	Dkr1.13 Billion
2010	22.17%	16.70%	0.82x	1.62x	Dkr1.35 Billion
2011	17.86%	14.26%	0.78x	1.61x	Dkr1.00 Billion
2012	8.39%	7.48%	0.69x	1.63x	Dkr-212.80 Million
2013	6.34%	5.60%	0.65x	1.75x	Dkr-493.10 Million
2014	-1.13%	-1.14%	0.53x	1.90x	Dkr-1.51 Billion
2015	-64.82%	-39.02%	0.68x	2.43x	Dkr-6.57 Billion
2016	12.49%	7.75%	0.77x	2.08x	Dkr241.60 Million
2017	21.54%	15.23%	0.87x	1.62x	Dkr1.41 Billion
2018	27.42%	21.86%	0.78x	1.61x	Dkr2.48 Billion
2019	18.32%	15.36%	0.49x	2.46x	Dkr1.21 Billion
2020	9.31%	8.95%	0.49x	2.12x	Dkr-116.30 Million
2021	7.21%	8.09%	0.47x	1.90x	Dkr-509.90 Million
2022	9.22%	10.50%	0.49x	1.80x	Dkr-161.90 Million
2023	10.39%	11.50%	0.53x	1.70x	Dkr85.50 Million
2024	12.57%	14.28%	0.39x	2.28x	Dkr642.00 Million
2025	12.82%	13.11%	0.45x	2.17x	Dkr701.70 Million

Industry Comparison

This section compares H Lundbeck A/S's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $6,750,736,094
Average return on equity (ROE) among peers: -4.83%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
H Lundbeck A/S (HLUN-A)	Dkr24.90 Billion	21.79%	1.17x	$1.09 Billion
H Lundbeck A/S (HLUN-B)	$13.48 Billion	6.34%	0.75x	$5.26 Billion
Stenocare AS (STENO)	$20.47 Million	-16.00%	0.06x	$7.70 Million

About H Lundbeck A/S

CO:HLUN-A Denmark Drug Manufacturers - Specialty & Generic

Market Cap

$1.09 Billion

Dkr6.97 Billion DKK

Market Cap Rank

#8736 Global

#44 in Denmark

Share Price

Dkr35.00

Change (1 day)

-1.13%

52-Week Range

Dkr26.10 - Dkr39.65

All Time High

Dkr41.55